Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT03318783

Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial (SUSHI)

Sponsor: Foundation for Anesthesia Education and Research

Conditions Delayed Cerebral Ischemia Endothelial Dysfunction Subarachnoid Hemorrhage, Aneurysmal Vasospasm, Cerebral

Updated 8 times since 2017 Last updated: Dec 31, 2020 Started: May 2, 2018 Primary completion: Apr 3, 2019 Completion: Jan 9, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Delayed Cerebral Ischemia and Endothelial Dysfunction and is currently completed. Foundation for Anesthesia Education and Research leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Feb 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Feb 2021 [monthly]

Completed PHASE1_PHASE2
Sep 2020 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

May 2019 — Sep 2020 [monthly]

Active Not Recruiting PHASE1_PHASE2

Status: Recruiting → Active Not Recruiting
Jun 2018 — May 2019 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Nov 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Foundation for Anesthesia Education and Research
GlaxoSmithKline
Oregon Health and Science University

Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States